Case Series: Unilateral Amygdala Ablation Ameliorates Post-Traumatic Stress Disorder Symptoms and Biomarkers.


Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
15 09 2020
Historique:
received: 11 10 2019
accepted: 12 01 2020
pubmed: 8 4 2020
medline: 26 1 2021
entrez: 8 4 2020
Statut: ppublish

Résumé

Post-traumatic stress disorder is a severe psychobiological disorder associated with hyperactivity of the amygdala, particularly on the right side. Highly selective laser ablation of the amygdalohippocampal complex is an effective neurosurgical treatment for medically refractory medial temporal lobe epilepsy that minimizes neurocognitive deficits relative to traditional open surgery. To examine the impact of amygdalohippocampotomy upon symptoms and biomarkers of post-traumatic stress disorder. Two patients with well-documented chronic post-traumatic stress disorder who subsequently developed late-onset epilepsy underwent unilateral laser amygdalohippocampotomy. Prospective clinical and neuropsychological measurements were collected in patient 1. Additional prospective measurements of symptoms and biomarkers were collected pre- and post-surgery in patient 2. After laser ablation targeting the nondominant (right) amygdala, both patients experienced not only reduced seizures, but also profoundly abated post-traumatic stress symptoms. Prospective evaluation of biomarkers in patient 2 showed robust improvements in hyperarousal symptoms, fear potentiation of the startle reflex, brain functional magnetic resonance imaging responses to fear-inducing stimuli, and emotional declarative memory. These observations support the emerging hypothesis that the right amygdala particularly perpetuates the signs and symptoms of post-traumatic stress disorder and suggests that focal unilateral amydalohippocampotomy can provide therapeutic benefit.

Sections du résumé

BACKGROUND
Post-traumatic stress disorder is a severe psychobiological disorder associated with hyperactivity of the amygdala, particularly on the right side. Highly selective laser ablation of the amygdalohippocampal complex is an effective neurosurgical treatment for medically refractory medial temporal lobe epilepsy that minimizes neurocognitive deficits relative to traditional open surgery.
OBJECTIVE
To examine the impact of amygdalohippocampotomy upon symptoms and biomarkers of post-traumatic stress disorder.
METHODS
Two patients with well-documented chronic post-traumatic stress disorder who subsequently developed late-onset epilepsy underwent unilateral laser amygdalohippocampotomy. Prospective clinical and neuropsychological measurements were collected in patient 1. Additional prospective measurements of symptoms and biomarkers were collected pre- and post-surgery in patient 2.
RESULTS
After laser ablation targeting the nondominant (right) amygdala, both patients experienced not only reduced seizures, but also profoundly abated post-traumatic stress symptoms. Prospective evaluation of biomarkers in patient 2 showed robust improvements in hyperarousal symptoms, fear potentiation of the startle reflex, brain functional magnetic resonance imaging responses to fear-inducing stimuli, and emotional declarative memory.
CONCLUSION
These observations support the emerging hypothesis that the right amygdala particularly perpetuates the signs and symptoms of post-traumatic stress disorder and suggests that focal unilateral amydalohippocampotomy can provide therapeutic benefit.

Identifiants

pubmed: 32259241
pii: 5817377
doi: 10.1093/neuros/nyaa051
pmc: PMC7593359
doi:

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

796-802

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR002381
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS104953
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002378
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH100122
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS088748
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH116364
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 by the Congress of Neurological Surgeons.

Références

Psychiatry Res. 2009 May 15;167(1-2):151-60
pubmed: 19345420
Am J Psychiatry. 2005 Feb;162(2):214-27
pubmed: 15677582
Acta Psychiatr Scand. 2006 Apr;113(4):360-3; discussion 363-4
pubmed: 16638081
J Psychiatr Res. 2013 Oct;47(10):1469-78
pubmed: 23827769
JAMA. 2000 Apr 12;283(14):1837-44
pubmed: 10770145
Psychol Assess. 2008 Jun;20(2):131-8
pubmed: 18557690
Ann N Y Acad Sci. 2010 Oct;1208:142-9
pubmed: 20955336
Ann Neurol. 2018 Mar;83(3):575-587
pubmed: 29420840
Neuropsychopharmacology. 2016 Mar;41(4):1156-65
pubmed: 26289143
Arch Gen Psychiatry. 2001 May;58(5):485-92
pubmed: 11343529
Gen Hosp Psychiatry. 2009 Nov-Dec;31(6):505-14
pubmed: 19892208
Front Psychiatry. 2016 Sep 14;7:156
pubmed: 27683563
Nat Neurosci. 2008 Feb;11(2):232-7
pubmed: 18157125
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
J Abnorm Psychol. 2008 May;117(2):479-84
pubmed: 18489226
Neuroimage Clin. 2017 Nov 21;17:650-658
pubmed: 29204343
Am J Psychiatry. 2017 Dec 1;174(12):1163-1174
pubmed: 28715908
Psychosom Med. 2017 Jul/Aug;79(6):664-669
pubmed: 28306623

Auteurs

Kelly R Bijanki (KR)

Department of Neurosurgery, Baylor College of Medicine, Houston, Texas.
Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia.
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia.

Sanne J H van Rooij (SJH)

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia.

Timothy D Ely (TD)

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia.

Jennifer S Stevens (JS)

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia.

Cory S Inman (CS)

Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia.

Rebecca E Fasano (RE)

Department of Neurology, Emory University School of Medicine, Atlanta, Georgia.

Sierra E Carter (SE)

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia.

Sterling J Winters (SJ)

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia.

Justin R Baman (JR)

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia.

Daniel L Drane (DL)

Department of Neurology, Emory University School of Medicine, Atlanta, Georgia.
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.

Tanja Jovanovic (T)

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia.
Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan.

Jon T Willie (JT)

Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia.
Department of Neurology, Emory University School of Medicine, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH